Men's Health After 40: Which Checks Actually Matter?
Blood pressure, cardiometabolic risk, colorectal screening, smoking history, sexual health, prostate decisions, and testosterone—without turning age 40 into a universal test package.
Short answer
Start with risks that change outcomes; add sex-specific decisions with context.
Blood pressure, weight and waist context, lipids, diabetes risk, tobacco, alcohol, activity, sleep, vaccines, mental health, and age-appropriate cancer screening usually matter more than a broad hormone panel. Prostate screening and testosterone testing require a defined question and shared decision-making.
Cardiometabolic risk
Hypertension, diabetes, lipids, smoking, sleep apnea, kidney disease, and activity account for major preventable burden.
Cancer prevention
Colorectal and selected lung screening have defined eligibility; prostate recommendations differ between the U.S. and Brazil.
Sexual health
Erectile, libido, fertility, urinary, pain, and relationship concerns deserve direct, confidential assessment.
Hormones
Symptoms plus repeatedly low, properly timed testosterone—not age or one result—support a hypogonadism diagnosis.
Bottom lineA useful checkup is a sequence of decisions tied to benefit and risk—not the largest possible list of tests.
Decisions in context
What common ‘men's health’ tests can and cannot answer
MERHI ONE evidence review
Prevention is strongest when each test has a defined pathway
U.S. and Brazilian recommendations are kept separate where policy and thresholds differ.
Adults should be screened for high blood pressure—and elevated office readings should be confirmed.1
The USPSTF recommends adult screening and confirmation outside the clinical setting before treatment when appropriate. Frequency depends on age, prior values, and risk.
Diabetes screening is not simply ‘annual insulin for every man over 40.’2
In the U.S., the USPSTF recommends screening adults ages 35–70 with overweight or obesity. Symptoms, pregnancy history, medications, ethnicity, and other risks can alter assessment; Brazilian pathways may differ.
Colorectal cancer screening has clear benefit in eligible adults.3
The USPSTF recommends screening average-risk adults 45–75 and selective decisions at 76–85. Stool tests and visualization strategies have different intervals, burdens, and follow-up requirements.
PSA screening is not one universal rule after 40.4,5
The current U.S. USPSTF statement supports individual decision-making at ages 55–69 and recommends against screening at 70 or older; an update is in progress. Brazil's Ministry of Health and INCA recommend against population screening of asymptomatic men while supporting early diagnosis of symptoms.
Testosterone deficiency requires symptoms and consistently low levels.6,7
Endocrine guidance recommends against routine population screening and requires compatible clinical features plus unequivocally and consistently low testosterone, with repeat morning testing and evaluation of cause.
Testosterone is not a universal anti-aging or fertility treatment.6,7
Exogenous testosterone can suppress sperm production and requires review of hematocrit, prostate context, sleep apnea, cardiovascular factors, and formulation-specific risks. FDA labeling and indications continue to evolve.
Brazil ↔ United States
The evidence is shared. Screening and care pathways may differ materially.
The biological question is international, but eligible ages, intervals, risk thresholds, shared-decision language, coverage, and referral pathways must follow current local guidance.
United States
Apply current U.S. professional or public-health guidance and local coverage rules.
Brazil
Apply current Brazilian Ministry of Health and relevant professional-society guidance.
Practical review
Eight conversations with more value than a giant panel
Blood pressure and lipids
Measure correctly and estimate overall cardiovascular risk.
Glucose and body composition
Use weight, waist, glucose criteria, medicines, family history, and lifestyle together.
Tobacco and lung eligibility
U.S. low-dose CT applies only to defined age and smoking history—not to every former smoker.
Colorectal pathway
Select an evidence-based method and plan follow-up before ordering.
Prostate decision
Separate urinary symptoms and diagnostic evaluation from screening an asymptomatic person.
Sexual and urinary function
Ask directly; vascular, neurologic, hormonal, medication, prostate, and psychological factors can overlap.
Sleep, mood, and alcohol
Snoring, sleepiness, depression, anxiety, stress, and alcohol can affect energy, blood pressure, and sexual function.
Vaccines and prevention
Use age, conditions, occupation, travel, prior doses, and local schedules.
Common mistakes
What makes a men's health visit less useful
More testing can create more false positives without improving outcomes.
Order every hormone
Broad panels without symptoms or a diagnostic question generate incidental findings.
Call PSA mandatory
The balance of benefit and harm is preference- and country-sensitive.
Ignore colorectal screening
A ‘prostate-focused’ visit can miss a prevention strategy with stronger population evidence.
Treat one low testosterone
Timing, illness, sleep, obesity, medicines, assay variation, and repeat measurement matter.
Use testosterone for fertility
Exogenous therapy can suppress spermatogenesis.
Reduce health to sex
Cardiovascular, mental, metabolic, sleep, vaccination, and social risks often dominate outcomes.
Questions
What men commonly ask after 40
Do I need an annual PSA at 40?+
Not automatically. U.S. and Brazilian policies differ, and age, symptoms, risk, family history, ancestry, values, and potential harms matter.
Should every man test testosterone?+
No. Test when compatible symptoms or signs create a clinical question; confirm a low result properly before diagnosis.
Does low libido prove low testosterone?+
No. Sleep, mood, relationship context, medicines, alcohol, vascular disease, pain, and other causes are common.
Which cancer screen starts at 45 in the U.S.?+
Average-risk colorectal screening. Higher-risk people may need an earlier or different pathway.
Does erectile dysfunction matter beyond sex?+
It can share vascular and metabolic risks and deserves assessment rather than stigma.
What symptoms need prompt evaluation?+
Blood in urine or stool, a testicular mass, new neurologic symptoms, chest pain, severe urinary retention, or rapidly progressive symptoms warrant prompt care.
References
Prevention, screening, hormones, and local policy
Recommendations are tied to the correct population and country rather than presented as a universal male package.
- 01Open source ↗
U.S. Preventive Services Task Force · 2021
Hypertension in Adults: Screening
- 02Open source ↗
U.S. Preventive Services Task Force · 2021
Prediabetes and Type 2 Diabetes: Screening
- 03Open source ↗
U.S. Preventive Services Task Force · 2021
Colorectal Cancer: Screening
- 04Open source ↗
U.S. Preventive Services Task Force · 2018 · update in progress
Prostate Cancer: Screening
- 05Open source ↗
Instituto Nacional de Câncer · Brasil · 2023 · current
Professional guidance on prostate cancer early detection and population screening
- 06Open source ↗
Endocrine Society · 2018 · reaffirmed 2026
Testosterone Therapy in Men With Hypogonadism
- 07Open source ↗
U.S. Food and Drug Administration · 2026
Testosterone Information
- 08Open source ↗
U.S. Preventive Services Task Force · 2021
Lung Cancer: Screening
- 09Open source ↗
Ministério da Saúde do Brasil · current
National Policy for Comprehensive Men's Health Care
Editorial record